OMDA vs ZBH: fair value comparison
Omada Health, Inc. and Zimmer Biomet Holdings, Inc. · Updated 2026-10-19
OMDA's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, ZBH currently ranks higher by quality score.
| OMDA | ZBH | |
|---|---|---|
| Verdict | Awaiting full valuation | Undervalued |
| Last price | $17.63 | $89.14 |
| 12-month range | $10.94–$26.78 | $79.58–$103.18 |
| Rank by discount to fair value | — | #24 of 108 Healthcare |
| Rank by quality score | #71 of 301 Healthcare | #69 of 301 Healthcare |
| Quality grade | B | B |
| Leverage | — | Moderate |
| Margin trend | Expanding | Contracting |
| Revenue growth | High | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | — |
| DCF cross-check | — | Fairly Valued |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: OMDA fair value analysis · ZBH fair value analysis